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1. Introduction 
When the discovery of giant banded, salivary chromosomes in Drosophila was made by 
Painter in 1934, it gave a tremendous impact to the cytological work carried out in 
Drosophila. This made it possible to identify the chromosomes individually and also to 
discern the specific segments of the chromosome. Followed by this, cytogenetics bloomed 
with the establishment of chromosome number in man as 46 in the year 1956. Since then, lot 
of advancements and improvements have taken place over the years and combination of 
techniques have made cytogenetics as an undisputable source in diagnosing the various 
genetic disorders and now, human cytogenetics has completed its glorious 50 years after the 
discovery of chromosome number in normal human cells. This chapter provides an insight 
into the fundamentals of cytogenetics and its importance in the diagnosis of commonly 
occurring syndromes and disorders.  
2. History of cytogenetics 
When the genetic importance of polytene chromosomes of Diptera was rediscovered in the 
early thirties, almost every Drosophila geneticist started studying the salivary glands.  
Nageli, the Swiss botanist first described thread like structures in the nuclei of plant cells in 
the 1840s and called them “transitory cytoblasts”, which represented what now are called 
chromosomes. Later, the term “chromosome” was coined by Waldeyer in 1888 after staining 
techniques had been developed which made them better discernible (chromos = Greek for 
colour; soma = Greek for body).  In 1909, Johannsen coined the term ‘gene’. This triggered 
the beginning of modern cytogenetics, but yet, the progress was moving at a snail’s pace. 
Still, attempts were going on to find the number of chromosomes, which became a serious 
issue and a matter of great concern among the various researchers. The quality of 
chromosomes were poor and the numbers varied each and every time. Even determining 
the diploid number of a mammalian species was considered a difficult accomplishment. The 
chromosomes were crowded in metaphase and considerations of biological function of the 
chromosomes and in particular, of modern genetics were beyond the scope of cytological 
research in the 19th century. It was quite cumbersome to obtain nice slides with good 
metaphase spreads for easy counting. However, in 1950s, there were advent of new 
techniques for chromosome preparations, like addition of colcemid and hypotonic 
treatment, led to the establishment of the diploid number of chromosomes in man as 46 (Tjio 
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& Levan, 1956) and the peripheral leucocyte culture method of Moorehead et al. (1960) was 
adopted by many cytogeneticists. Once the correct description of the normal human 
chromosome number was established, chromosome abnormalities were recognized to be 
clearly associated with specific congenital defects. It was possible to arrange the 
chromosomes in different groups based on their size and location of the centromere which 
enabled easy counting as well as detection of numerical chromosome aberrations like 
trisomy 21 in Down syndrome (Lejeune et al. 1959), 45X in Turner syndrome (Ford et al. 
1959), 47XXY in Klinefelter syndrome (Jacobs & Strong, 1959), trisomy 13 (Patau et al. 1960) 
and trisomy 18 (Edwards et al. 1960), Philadelphia chromosome, a structural aberration 
involving chromosomes 9 and 22, was recognized in a patient with chronic myeloid 
leukemia (Nowell & Hungerford, 1960). The metaphase chromosomes were classified into 7 
groups based on the Denver classification (1960), with revisions at the London Conference 
(Hamerton et al. 1963) and the Chicago Conference (1966). Karyotype is the normal 
nomenclature where the chromosomes are arranged in homologous pairs in a systematic 
manner to describe the normal or abnormal chromosomal complement of an individual, 
tissue or cell line (ISCN, 2005). Jau-hong Kao et al. (2008) described chromosome 
classification based on the band profile similarity along approximate medial axis. This was 
soon followed by amniocentesis to determine the chromosomal abnormalities in fetal cells in 
the amniotic fluid, which formed the core of prenatal genetic diagnosis (Steele & Breg, 1966). 
After the advent of these protocols and discoveries, the heyday of cytogenetics research 
appeared to be over (Hans Zellweger and Jane Simpson, 1977), the power of cytogenetics 
analysis improved with the development of staining protocols by Caspersson et al.  (1968), 
that made chromosomes of the same group, which previously could not be distinguished 
from each other, discernible. This banding pattern was based on a fluorescent staining 
technique and the fluorescence intensity quickly quenched which made the technique less 
optimal for routine studies of patients. Hence, several other banding techniques were 
developed like G-, R-, C- and NOR banding each having their own specific properties and 
applications (Rooney, 2001). These banding patterns became the barcodes with which 
cytogeneticists could easily identify chromosomes, detect subtle deletions, inversions, 
insertions, translocations, fragile sites and other more complex rearrangements and refine 
breakpoints (Caspersson et al. 1970).  
3. Cytogenetics  
Cytogenetics is the study of the structure and properties of chromosomes, chromosomal 
behaviour during somatic cell division in growth and development (mitosis) and germ cell 
division in reproduction (meiosis), chromosomal influence on the phenotype and the factors 
that cause chromosomal changes (Hare & Singh, 1979). Discovery of new techniques, 
improvements of existing techniques or new combinations of well established techniques 
are often followed by progress in the biosciences. This is strikingly exemplified by the 
development of cytogenetics in the last 100 years.  
3.1 Chromosomes and normal chromosome complement 
Chromatins are dark staining materials present in the nucleus of a cell and in interphase, 
these chromatin materials are organised into a number of long, loosely coiled, irregular 
strands or threads called the chromatin reticulum. At the time of cell division, these 
chromatin bodies condense into shorter and thicker threads called chromosomes, that carry 
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the genes and functions in the transmission of hereditary information. In a normal diploid 
cell, there are 46 chromosomes (23 chromosome pairs), where one of each pair is derived 
from the father and the other from the mother of the individual. The first 22 pairs are called 
the autosomes (non-sex chromosomes) and the 23rd pair is called the sex-chromosomes. In 
males, the 23rd pair is XY and in females, it is XX. The X-chromosome is maternally derived 
and the Y-chromosome is paternally derived. The karyotypes of a normal male (Figure 1) 
and female (Figure 2) are presented. Except in the case of mosaic individuals (where they 
have two or more populations of cells which differ in chromosome number), all the cells of 
an individual have the same chromosome complement in their diploid cells. In the case of 
gametic cells (sperm and ovum), or otherwise called haploid cells, they have only single 
chromosome from each pair.  
 
 
Fig. 1. A karyotype of a normal male (46,XY) 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
3.2 Cytogenetic analysis of chromosomes  
3.2.1 Whole blood culture 
The main advantage of whole blood culture is that blood is one of the most and easily 
accessible human tissues. Also, it has a very good growth potential after mitogenic 
stimulation. They have a cell cycle which is well characterized and the results can be 
obtained after a culture duration of 3 days.  
3.2.1.1 Short term culture 
The most commonly used technique for preparation of chromosomes is peripheral blood 
culture. The materials and reagents needed for culture are as below. 
1. Sodium heparin – which is used as an anti-coagulant  
2. Culture medium (E.g. RPMI 1640, TC 199 etc.) – provides nutrients and amino acids 
needed for the growth of the cells 
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3. Fetal bovine serum – contains a rich variety of proteins that enhances the growth of cells  
4. Antibiotics – suppreses the growth of contaminants 
5. Mitogen – (E.g. Phytohaemagglutinin) – induces the cells to undergo mitosis 
6. Colchicine or its synthetic derivative, Colcemid – arrests cell division 
7. Potassium chloride solution (hypotonic treatment) – induces swelling of cells through 
osmosis  
8. Methanol: Acetic acid – for fixation of cells 
 
 
Fig. 2. A karyotype of a normal female (46,XX) 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
Blood is collected in sterile tubes containing sodium heparin. Whole blood, leucocytes 
separated from red blood cells or purified lymphocytes are put in culture medium 
supplemented with serum and antibiotics. Then, mitogen is added to induce mitosis. Once 
the cultures are set, they are incubated at 37ºC for 72 hours in a CO2 incubator. The cultures 
have to be shaken at least twice daily which significantly increases mitosis. Then, colchicine 
or its synthetic derivative, colcemid is added to the cultures few hours before harvesting 
(usually 2 to 3 hours) to arrest the cells in metaphase. Colcemid prevents formation of cell 
spindle and hence prevents cells from progressing to the next phase of the cell cycle, 
anaphase. Colcemid can also cause contraction of chromosomes if added in larger quantities 
or if the cells are exposed for a longer duration of time. This varies from laboratory to 
laboratory and hence needs optimisation to obtain chromosomes of good quality. After 
incubation for 72 hours, the centrifuge tubes in which the cultures are set is centrifuged at 
1000 rpm for 10 minutes. Then, the supernatant is discarded and the cells are gently 
suspended. To this, freshly prepared potassium chloride solution is added, called the 
hypotonic treatment. Potassium chloride causes swelling of the cells through the process of 
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osmosis and hence proper dispersion of chromosomes. The hypotonic treatment is achieved 
by incubating the centrifuge tubes in a CO2 incubator at 37ºC for about 30 minutes. Then, the 
process of centrifugation is repeated followed by addition of 3:1 methanol:acetic acid, which 
acts as a fixative. Methanol in the fixative denatures and precipitates the proteins by 
dehydration under acid conditions and acetic acid coagulates the nucleoproteins and casues 
swelling of cells thus counteracting the shrinking caused by methanol. The fixative 
penetrates the cells rapidly, preserves the chromosome structure and to a large extent, strips 
cytoplasmic proteins from cells. The fixative washes are repeated as many times as 
necessary until a clear cell button is obtained at the bottom of the tube. Then, the 
chromosomes are prepared by dropping the cell suspension on a clean, grease free slide, 
where, the drop spreads out and the chromosomes get fixed on the slides. Once the slides 
are prepared, suitable staining techniques are carried out as needed for the diagnosis of 
chromosomal disorders. 
3.2.1.2 Bone marrow culture  
The bone marrow culture is used to identify chromosome anomalies in hematopoietic cells, 
especially for hematological disorders like pre-leukemia and leukemia. Bone marrow 
aspirate of about 0.5 to 2.0 ml is collected in a heparinized syringe. Strict aseptic techniques 
are a must right from the beginning of collection until the final process is completed. Bone 
marrow is collected in transport media and mixed thoroughly. Then, the samples are spun 
at around 900 rpm for 10 minutes followed by pipetting off the supernatant. This is then 
followed by addition of about 1ml of sample to complete culture media (medium + Fetal 
bovine serum + L-glutamine + Antibiotics). After about 45 minutes, colcemid is added to 
this and mixed thoroughly. Then, the cultures are incubated at 37ºC in a CO2 incubator for 
24 hours. This is followed by the routine hypotonic and fixative treatments as for the whole 
blood culture. The chromosomes are prepared on clean grease free slides, stained and 
examined under microscope for analysis.  
3.2.2 Banding techniques 
The different banding techniques allow precise identification of each chromosome as well as 
to detect structural chromosomal rearrangements. A combination of several banding 
techniques also help in obtaining the information necessary for chromosomal analysis. 
3.2.2.1 Q-banding 
This banding technique does not require any prior treatment of the chromosomes but 
requires a fluorescent microscope for analysis. Caspersson et al. (1970) discovered one of 
the first chromosome banding techniques, which involves staining chromosomes with a 
fluorochrome, such as quinacrine mustard or quinacrine dihydrochloride, and examining 
them with fluorescence microscopy. The Q-bands appear along each chromosome in 
alternating bright and dull bands with varying intensity. However, Q-banding does not 
permit permanent preparations. Certain antibiotics like anthracyclines produce 
fluorescent bands similar to Q-bands and are more stable than those produced by 
quinacrine.  
3.2.2.2 G-banding 
G-bands are produced by staining the chromosomes with a stain, Giemsa. This is done by 
treating the chromosomes with substances (usually trypsin), that alters the structure of 
www.intechopen.com
 
Advances in the Study of Genetic Disorders 50
proteins followed by staining with a Giemsa solution (Rowley, 1973).  It is the most common 
method of banding, as it produces the same banding pattern as quinacrine with even greater 
resolution; it allows permanent preparations and does not necessitate the use of fluorescence 
microscopy. Thus, G-band patterns can be used to pair and identify each of the human 
chromosomes accurately.  
3.2.2.3 R-banding 
R-bands are just the reverse of G-bands, which can be produced by a variety of methods. A 
modification of method of Dutrillaux and Lejeune (1971) involves thermic denaturation in 
Earle’s balanced salt solution (at 87ºC), which is the most common method. Since the 
staining ability of the chromosomes is somewhat lost due to heating, the use of phase 
contrast objectives gives a better contrast of the chromosomes for analysis.  
3.2.2.4 C-banding 
C-bands localize the heterochromatic regions of chromosomes. Pardue & Gall (1970) first 
reported C-bands in 1970 when they discovered that the centromeric region of mouse 
chromosomes is rich in repetitive DNA sequences and stains dark with Giemsa. The original 
method of Arrighi and Hsu (1971) involves treating the slides with 0.2 N hydrochloric acid 
followed by treatment with RNAse and sodium hydroxide. Many chromosomes have 
regions that differ among individuals but have no pathological importance. These 
polymorphic regions can be visualized optimally with C-band methods and are most often 
seen on acrocentric chromosomes, the centromeric region of chromosomes 1, 9, and 16, and 
the distal portion of the Y chromosome. C-banding is also useful to show chromosomes with 
multiple centromeres, to study the origin of diploid molar pregnancies and true 
hermaphroditism and to distinguish between donor and recipient cells in bone marrow 
transplantation. 
3.2.2.5 T-banding 
This method involves staining the telomeric (end) regions of the chromosomes. Dutrillaux 
(1973) treated the slides with either phosphate buffer or Earle’s balanced salt solution and 
then stained using mixed Giemsa solution to produce the T-bands.  
3.2.2.6 CT-banding 
Scheres, (1974) developed a method to stain both the centromeric heterochromatin as well as 
the telomere of chromosomes. He treated the slides with barium hydroxide to produce the 
CT-bands. Chamla & Ruffie (1976) obtained complete C- and T-bands by incubating the 
slides in Hank’s balanced salt solution.  
3.2.2.7 Nucleolar Organizing Region-banding 
Nucleolar organizing region (NOR)–banding is a technique that stains NORs of 
chromosomes (Matsui & Sasaki, 1973). These regions are located in the satellite stalks of 
acrocentric chromosomes and house genes for ribosomal RNA. NOR-bands may represent 
structural non-histone proteins that are specifically linked to NOR and bind to ammoniacal 
silver. Goodpasture et al. (1976) developed a simple silver nitrate staining technique that is 
now used widely. NOR-banding is useful in clinical practice to study certain chromosome 
polymorphisms, such as double satellites. This method is also helpful to identify satellite 
stalks that are occasionally seen on non-acrocentric chromosomes. 
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3.2.2.8 The choice of banding technique 
For routine analysis, the banding technique using trypsin and Giemsa became the most 
accepted worldwide (Seabright, 1971). Since the banding pattern enabled the detection of 
various structural aberrations like translocations, inversions, deletions, and duplications 
next to the already well-known numerical aberrations, not only potentially unbalanced cases 
(patients) could be studied but also healthy individuals as possible carriers of a balanced 
aberration. For instance, healthy family members of already known carriers and couples 
suffering from repetitive spontaneous abortions were cytogenetically investigated 
(Dominique FCM Smeets, 2004). 
3.2.2.9 High resolution banding 
Despite the above banding patterns, resolution of chromosome studies remained relatively 
limited with an approximate count of 500 bands per haploid genome (resolution ≈ 6 million 
base pairs ≈ 50 genes per band) because the total number of bands produced on metaphase 
chromosomes are less and it is difficult to detect rearrangements involving small portions of 
chromosomes due to excessive condensation. This was improved by the development of so-
called high-resolution banding by Yunis (1976) which was achieved by synchronizing the 
lymphocyte cultures and obtaining more number of cells in pro-metaphase or even 
prophase (increasing resolution from 500 to over 1000 bands in a haploid genome). High 
resolution cytogenetics provides precision in the delineation of chromosomal breakpoints 
and assignment of gene loci, greater than with earlier techniques, since analysis of late 
prophase sub-banding reveals more than twice the number of bands seen at metaphase 
(Sawyer & Hozier, 1986). By applying this technique, several already well-known clinical 
syndromes like Prader Willi and Angelman syndrome with a deletion at the proximal long 
arm of chromosome 15, Smith-Magenis and Miller-Dieker syndrome with (different) 
deletions in the short arm of chromosome 17 and DiGeorge/Velo Cardio Facial (VCF) 
syndrome with deletions in the long arm of chromosome 22 could be linked to small 
chromosome aberrations and the concept of the micro-deletion or contiguous gene 
syndrome was born (Schmickel, 1986).   
3.2.2.10 Sex chromatin analysis 
The number of sex chromatin bodies is one less than the number of X chromosomes in the 
chromosome complement. This is obtained by taking buccal smears on a clean slide 
followed by fixing them in ethanol, air drying, hydrolysing in  hydrochloric acid, washing 
in distilled water to remove the acid and then finally staining using cyrstal violet.  
The presence of a chromatin mass, called the “Barr body” indicates a chromatin positive 
cell.  
3.3 Specialized techniques to visualize chromosomes 
3.3.1 Sister Chromatid Exchange (SCE) 
SCE staining is accomplished in cell cultures by incorporating BrdU (bromodeoxyuridine) 
(in place of thymidine) into replicating cells for 2 cell cycles. As a result of semi-conservative 
DNA replication, chromosomes have one chromatid with BrdU in one strand of DNA and 
the other chromatid has BrdU in both strands of DNA. This produces an acridine 
fluorescence pattern in which one chromatid fluoresces more brightly than the other 
chromatid. Sister chromatid exchanges appear as an interchange between sister chromatids 
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of brightly and dully fluorescent segments. The biologic importance of SCEs is uncertain, 
but some mutagens and carcinogens increase their frequency (Perry & Evans, 1975).   
3.3.2 Fragile sites and chromosome breakage 
Certain uncondensed portions of DNA in chromosome structure can be visualized as gaps 
in the staining pattern and these gaps are prone to chromosome breakage. Gaps that are 
consistently seen at the same chromosome locus are called fragile sites. Fragile sites can be 
induced by modifying the culture media in ways that interfere with DNA synthesis and are 
best visualized in chromosomes by using non-banding or Q-banding methods. Some fragile 
sites are associated with specific medical conditions such as fragile X syndrome, (Figure 3), 
which is associated with a fragile site at Xq27.3 (Lubs, 1969). The symptoms associated with 
the syndrome include mental retardation, altered speech patterns and other physical 
attributes. The syndrome is named so because it is related to the tip of the X chromosome 
that breaks more frequently that other chromosomal regions.  
 
 
Fig. 3. A micrograph showing normal X-chromosomes (on the left) and an abnormal  
X-chromosome with a fragile-X site (indicated by arrow) 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
3.4 Molecular cytogenetics 
3.4.1 Fluorescent in situ Hybridization (FISH) 
Even with the technique of high resolution chromosome banding, it was difficult to 
visualize the aberrations at the cytogenetics level. In 1986, Pinkel et al. (1986a) developed a 
method to visualize chromosomes using fluorescent-labeled probes called FISH. FISH 
allowed chromosomal and nuclear locations of specific DNA sequences to be seen through 
the microscope. FISH technology permits the detection of specific nucleic acid sequences in 
morphologically preserved chromosomes, cells and tissues. FISH can be performed on either 
metaphase or interphase cells and involves denaturing genomic DNA by using heat and 
formamide. Slide preparations are flooded with chromosome-specific DNA sequences 
attached to colored fluorochromes and incubated at 37°C. During this time, probe DNA 
anneals with complementary DNA sequences in the chromosomes. The presence or absence 
of FISH signals is observed with a fluorescence microscope. FISH probes are generally 
classified by where they hybridize in the genome or by the type of chromosome anomaly 
they detect. These techniques are useful in the work-up of patients with various congenital 
and malignant neoplastic disorders, especially in conjunction with conventional 
chromosome studies. Fluorescent tags are safer and simpler to use, can be stored 
indefinitely, give higher resolution which opened up prospects for simultaneously locating 
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several DNA sequences in the same cell by labelling them with different fluorochromes 
(Barbara J Trask, 2002). Using FISH, cytogeneticists could detect chromosomal abnormalities 
that involved small segments of DNA. Even more importantly, FISH opened up the nuclei 
of non-dividing cells to karyotype analysis. Using FISH and chromosome-specific probes, 
cytogeneticists could enumerate chromosomes, simply by counting spots in each nucleus 
(Pinkel et al. 1986b).  
3.4.2 Spectral Karyotyping (SKY) and Multicolour FISH (M-FISH) 
After the advent of FISH, where a single copy gene could fluoresce, a more powerful 
technology called SKY or M-FISH was developed. M-FISH allows all the 24 human 
chromosomes to be painted in different colours. By making use of various combinations and 
concentrations of fluorescent dyes, it is even possible to give every single chromosome a 
different color (SKY) which can be of particular use when dealing with complex aberrations 
often associated with various types of solid tumors. SKY or M-FISH enables production of 
chromosome-specific ‘paints’: combines fluorochromes to produce 24 colour combinations, 
one for each chromosome (Ried et al. 1992) and hence multicolour analyses. SKY paints the 
entire chromosome in the same colour, whereas in the case of M-FISH, various fluorescence 
dyes to represent different painting probes at the same time are used. This offers the 
simultaneous presentation of all 24 different human chromosomes with a single 
hybridization. The unequivocal colour signature for each chromosome enables the analysis 
of hidden or complex chromosome aberrations as well as the composition of marker 
chromosomes. These imaging systems can be programmed to classify each chromosomal 
segment automatically and they offer the first real hope of automated karyotype analysis. 
SKY and M-FISH have proved to be extremely useful in detecting translocations and other 
complex chromosomal aberrations. 
3.4.3 Comparative Genomic Hybridization (CGH)  
While FISH investigations have proved to be advantageous in many ways, it also has 
demerits. Like all probes, it has to be hybridized and later microscopically analyzed. 
Moreover such procedures were time-consuming and difficult to automate. This led to the 
development of technique of FISH called CGH (Kallioniemi et al. 1992).  Later, a further 
improved technique was developed which was an array based on comparative genomic 
hybridization (Sabina Solinas-Toldo et al. 1997; Albertson & Pinkel, 2003). In contrast to 
analysis carried out on banded chromosomes, CGH does not require preparation of 
metaphase chromosomes from the cells. Instead of hybridizing a labeled probe to human 
chromosomes on a slide, we now have the potential to print thousands of different and well-
characterized probes on a glass slide. Subsequently, complete isolated and fragmented DNA 
from the patient is labeled in a certain color and mixed with exactly the same amount of 
DNA of a normal control (or a mix of controls) which is labeled in a different color. This 
DNA mix is then hybridized to the denatured probe DNA on the glass slide. After several 
washing steps, the fluorescence pattern of each spot can be analyzed and the ratio of test 
(patient) over reference (control) is measured. The array-CGH is even more promising than 
the conventional CGH (Pinkel et al. 1998). Array-CGH is the equivalent of conducting 
thousands of FISH experiments at once and provides better quantification of copy number 
and more precise information on the breakpoints of segments that are lost or gained than 
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does conventional CGH. These techniques will tell us much more about changes and 
variation within the human genome.   
4. Prenatal genetic diagnosis 
The term prenatal diagnosis refers broadly to a number of different techniques and 
procedures that can be performed during a pregnancy to provide information about the 
health of a developing fetus. Prenatal diagnosis of chromosomal aberrations requires 
cytogenetic analysis of amniotic fetal cells (Verma et al. 1998). Amniocentesis is an 
invasive, well-established, safe, reliable, and accurate procedure performed during 
pregnancy to detect chromosomal abnormalities as well as other specific genetic diseases. 
Fuchs and Riis (1956) reported the first use of amniotic fluid examination in the diagnosis 
of genetic disease in 1956 in their seminal article in "Nature". The determination of fetal 
sex led to the prenatal management of patients with Haemophilia in 1960 and Duchenne 
muscular dystrophy in 1964.  Steele and Breg very importantly demonstrated in their 
seminal paper in the Lancet in 1966 that cultured amniotic fluid cells were suitable for 
karyotyping (Steele & Breg, 1966).  Cytogenetic investigation of spontaneous pregnancy 
losses provides the basic information for accurate genetic counseling (Neus Baena et al. 
2001). The prenatal genetic diagnosis is necessary in cases where the sonographic findings 
leads one to doubt on the chromosomal disorders, especially the syndromes associated 
with various trisomies. It is also warranted in individuals with a high risk of trisomic 
pregnancies based on pedigree analysis for chromosomal disorders to know the family 
history of trisomy, increased maternal age, and increased incidence of meiotic or mitotic 
non-disjunction and couples who are suspected or known to be carriers of inherited 
genetic disorders. 
4.1 Amniocentesis and amniotic fluid culture 
Amniocentesis is an invasive test during pregnancy that removes a small amount of fluid 
from the sac around the baby to look for birth defects and chromosomal problems. A 
reliable quality of preparations is important in amniocentesis as repeated removal of 
amniotic fluid and chorionic villi increases the risk of fetal loss. However, with good 
ultrasound scanning, samples can be obtained safely and reliably. Since, the cells in amniotic 
fluid consists of cells derived from skin, kidney, bladder, gut as well as from other fetal 
tissues, it is better to collect samples from multiple sites. A proper collection of sample along 
with proper culture technique leads to a proper interpretation of the results. Amniocentesis 
is done from 12 to 15 weeks of gestation for chromosomal analysis. There are basically two 
methods of culturing the cells; one is culturing and processing on coverslips, which retains 
the individual colonies of the cells and the other is culturing in flasks, removing the cells 
with trypsin, which mixes all the colonies in the flask.  
After the amniotic sample is received in the laboratory, the sample is centrifuged at 750 rpm 
for 10 minutes. The amniotic fluid is then carefully decanted from the cell pellet into a sterile 
test tube and then the cell pellet is re-suspended in amniotic fluid. Then, suitable medium 
supplemented with fetal bovine serum, L-glutamine and antibiotics are added and the 
cultures are incubated at 37ºC in 5% CO2 incubator. The cells are harvested at 8-10 days after 
culture, subjected to routine hypotonic and fixative treatments as for whole blood culture 
and the chromosomes are analyzed. 
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5. Syndromes associated with chromosomal abnormalities 
5.1 Down syndrome (Trisomy 21) 
Down syndrome represents one of the better-known cytogenetic diseases. In most of the 
cases, this is due to trisomy of chromosome 21 (where the chromosome 21 appears thrice). 
Various types of chromosome +21 anomalies can cause this syndrome. The extra 
chromosome results in abnormalities of the body and brain development. The physical 
development is slower and may also have delayed mental development. The symptoms of 
Down syndrome vary from one person to another ranging from mild to severe.  
Symptoms 
• Nose is flattened 
• Small ears and mouth 
• Upward slanting of the eyes 
• Flat face (hypoplastic maxilla) 
• Decreased muscle tone at birth 
• Single palmar crease of the hand 
• Rounded inner corner of the eyes  
• Wide, short hands with short fingers 
• Abundant nuchal skin at the nape of the neck 
• Head smaller than normal and abnormally shaped 
• Separated joints between the sutures of the skull bone 
• Brushfield spots (white spots on the coloured part of the eye) 
 
 
Fig. 4. A karyotype of a Down syndrome patient (47, XX,+21) 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
Other medical conditions may also be noticed in Down syndrome people like birth defects 
of heart (atrial septal defect or ventricular septal defect), dementia, problems related to eye 
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(cataract), hearing problem, dysplastic pelvis, sleep apnea and hypothyroidism. 
Currently, there is no known treatment for Down syndrome. However, certain defects 
require surgery like heart problems etc. The risk is higher among women aged 35 years 
and above and couples having a Down syndrome baby have an increased risk of having 
another baby with the condition. A typical karyotype of a Down syndrome patient is 
given in Figure 4. 
5.2 Edwards syndrome (Trisomy 18) 
Edwards syndrome is a rare genetic chromosomal syndrome where the child has an extra 
third copy of chromosome 18.  Most of the fetuses abort before term and is more severe than 
Down syndrome. This syndrome results in mental retardation and various physical defects 
which causes mortality of the infants at an early stage.  Delayed psychomotor development 
as well as pre and post natal growth failure are the most common findings associated with 
this syndrome. Sometimes, only some of the body cells have an extra copy of chromosome 
18. Hence, there is a mixed population of cells in the individual (called mosaicism). If the 
individual is a mosaic, then the individual exhibits fewer abnormalities compared to the 
typical Edwards syndrome features.  
Symptoms 
• Small face 
• Low set ears 
• Omphalocele 
• Upturned nose 
• Arthrogryposis 
• Cleft lip/palate  
• Cryptorchidism 
• Ptosis of eyelids 
• Prominent occiput 
• Overlapping fingers 
• Small jaw and mouth 
• Limited hip abduction  
• Drooping upper eyelids 
• Developmental retardation 
• Clubfoot or rocker bottom feet 
• Malformations of heart and kidney 
• Webbing of the second and third toes 
• Widely spaced small eyes with narrow eyelid folds 
 
 
Fig. 5. A micrograph of trisomy 18 (Edwards syndrome) in comparison with its 
corresponding normal chromosomes 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
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The Edwards syndrome is untreatable but treatment can be provided for certain 
symptoms of the disease. Proper attention should be paid on providing proper nutrition 
as well as to keep them clean as they are more prone to infections. The survival rate is 
very low in the Edwards syndrome as half of them die while in the womb. Of those born, 
fifty percent die within two or three months of their birth, while others die by the time 
they enter their first year. A typical karyotype of an Edwards syndrome patient is given in 
Figure 5.  
5.3 Patau syndrome (Trisomy 13) 
Patau syndrome is a genetic disorder in which a person has three copies of chromosome 13, 
instead of the usual two copies. Rarely, the extra material may be attached to another 
chromosome (translocation). Trisomy 13 can appear as complete trisomy 13 or as mosaic or 
as partial trsiomy 13. 
Symptoms 
• Hernias 
• Coloboma   
• Small eyes 
• Hypotonia 
• Polydactyly 
• Low set ears 
• Micrognathia 
• Microcephaly 
• Hypertonicity 
• Cleft lip/ palate  
• Epicanthal folds 
• Clenched hands 
• Single palmar crease 
• Skeletal abnormalities 
• Developmental retardation 
• Close-set eyes (eyes may actually fuse together into one) 
The infants who are born often have congenital heart disease (atrial septal defect, patent 
ductus arteriosus, ventricular septal defect). Most of the children with trisomy 13 die in the 
first month of their life. The patients with trisomy 13 also have other complictions like 
breathing difficulty, deafness, feeding problems, seizures and vision problems. Hence, 
treatment involves case by case basis. A typical karyotype of a Patau syndrome patient is 
given in Figure 6. 
 
 
Fig. 6. A micrograph of trisomy 13 (Patau syndrome) in comparison with its corresponding 
normal chromosomes 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
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5.4 Trisomy 9 syndrome 
Trisomy 9 is one of the rare chromosomal disorders in which the entire 9th chromosome 
appears three times rather than twice in cells of the body. However, there are other 
variations, which comprise of trisomy 9 mosaic, trisomy 9p, tetrasomy 9p, trisomy 9q and 
monosomy 9. This can occur either as a mosaic or non-mosaic pattern and may be caused by 
errors during the division of a parent's reproductive cells (meiosis) or during the division of 
body tissue cells (somatic cells) early in the development of the embryo (mitosis). Non-
mosaic or complete trisomy 9 is a lethal diagnosis, with most fetuses dying prenatally or 
during the early postnatal period with most of the cases ending in spontaneous abortion in 
the first trimester.  
Symptoms 
• Club foot 
• Small face 
• Micropenis 
• Low set ears 
• Clinodactyly 
• Webbed neck 
• Micrognathia 
• Bulbous nose 
• Brachydactyly 
• Ear anomalies 
• Hypertelorism 
• Short sternum 
• Cyrptorchidism 
• Abnormal brain 
• Wide fontanelles 
• Bilateral club foot 
• Prominent occiput 
• Mental retardation 
• High arched palate 
• Rocker bottom feet 
• Small, deep set eyes 
• Overlapping fingers 
• Limited hip abduction 
• Abnormal hands and feet 
• Developmental retardation  
• Upslanting palpebral fissures 
• Head – larger and cloverleaf shaped 
 
 
Fig. 7. A micrograph of trisomy 9 in comparison with its corresponding normal chromosomes 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
www.intechopen.com
 
Cytogenetic Techniques in Diagnosing Genetic Disorders 59 
The infants who are born have congenital heart defects, kidney anomalies, musculoskeletal, 
genital and/or additional abnormalities. Most of those individuals that survive to be born at 
term are mosaics. Infants with non-mosaic trisomy 9 are more severely affected than those 
with mosaicism. The incidence and severity of malformations and mental deficiency 
correlate with the percentage of trisomic cells in the different tissues.  A typical karyotype of 
a Trisomy 9 syndrome patient is given in Figure 7. 
5.5 Turner syndrome 
Turner syndrome, gonadal dysgenesis or gonadal agenesis represents a special variant of 
hypergonadotrophic hypogonadism, and is due to the lack of the second sex chromosome 
or parts of it. The wide range of somatic features in Turner syndrome is due to a number 
of different X-located genes. Though many karyotype abnormalities have been described 
in association with Turner syndrome, monoclonal monosomy X and its various 
mosaicisms, each with an X monosomic (XO) cell clone, are the most frequent karyotype 
anomalies.  
Symptoms 
• Dry eyes 
• Infertility 
• Short stature  
• Vaginal dryness 
• Broad, flat chest  
• Drooping eyelids 
• Wide carrying angle 
• Primary amenorrhea 
• Widely spaced nipples 
• Swollen hands and feet 
• Wide and webbed neck 
• Underdeveloped breasts 
• Scanty pubic and axillary hair 
• Absence of secondary sexual characters 
• Rudimentary uterus and bilateral streak ovaries 
 
 
Fig. 8. A micrograph of Turner (XO) in comparison with its corresponding normal (XY) 
chromosomes 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
The symptoms of this syndrome have been logically deduced to be caused by a single 
dosage of genes that are normally present and active in two dosages. Growth hormone may 
be advocated in a child with Turner syndrome to grow taller. The Turner syndrome patients 
can have a normal life though they are prone to complications like arthritis, cataracts, 
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diabetes, heart defects, high blood pressure, renal problems, ear infections, obesity etc.  A 
typical karyotype of a Tunrner syndrome patient is given in Figure 8. 
5.6 Klinefelter syndrome 
Klinefelter syndrome is the presence of an extra X chromosome in a male. The XXY 
karyotype is the most frequent of this syndrome.  
Symptoms 
• Infertility 
• Thinness 
• Tall stature 
• Gynecomastia 
• Cryptorchidism 
• Delayed talking 
• Speech difficulty 
• Sparse facial hair 
• Difficulty writing 
• Delayed language 
• Small firm testicles 
• Normal intelligence 
• Muscular hypotonia 
• Inability to produce sperm 
• Sparse pubic and axillary hair 
• Abnormal legs, short trunk, shoulder equal to hip size 
Hormonal treatment may be advocated which may help the growth of body hair, improve 
the apperance of muscles, increase libido and strength. Some of the complications include 
enlarged teeth with a thinning surface (taurodontism), depression, learning disabilities, 
osteoporosis and breast cancer in men.  A typical karyotype of a Klinefelter syndrome 
patient is given in Figure 9. 
 
 
Fig. 9. A micrograph of Klinefelter (XXY) in comparison with its corresponding normal (XY) 
chromosomes 
(Reproduced courtesy of Human Genome Centre, Universiti Sains Malaysia, Malaysia) 
6. Conclusion 
So far, no system can classify banded chromosomes as robustly and accurately as a skilled 
cytogeneticist, despite the millions of dollars that have been invested in automated 
karyotype analysis since 1968. Currently cytogenetics is paving its way into the molecular 
approaches in deciphering the structure, function and evolution of chromosomes. Still, 
conventional cytogenetics where routine banding techniques are employed remains a 
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simple and popular technique to get an overview of the human genome as a whole 
(Thirumulu Kannan Ponnuraj & Zilfalil Alwi, 2009). Routine banded karyotype analysis 
can now be combined with M-FISH and other molecular techniques leading to more 
precise detection of various syndromes in children. Through the analysis of chromosome 
banding patterns, thousands of chromosomal abnormalities have been associated with 
inherited or de novo disorders, generating many leads to the underlying molecular causes 
of these disorders and today, when high resolution genetic linkage analysis can be 
conducted easily, the discovery of a patient whose disorder is caused by a gross 
chromosomal abnormality is heralded as a valuable resource for locating the disease gene. 
Solid tumors also present a myriad of complex chromosomal aberrations and each is a 
possible clue to tumor initiation and progression. The challenge is to navigate from the 
visible morphological alteration to the DNA sequence level. In other words, chromosomal 
abnormalities exist as nature’s guide to the molecular basis of many unexplained human 
disorders. Hence, cytogenetics continue to remain as indispensable tools for the diagnosis 
of various genetic disorders which gives an overall picture of the whole genome for 
analysis. This could possibly also pave a way for treatment and management related to 
chromosomal disorders.  
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